HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: Study With Dual Therapy Including Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) in Virologically Suppressed HIV-1 Infected Patients Experiencing Inconvenience, Toxicity, Negative Impact on Co-morbidities or Risk of Drug-drug Interactions With Their Current Regimen [Phase 3]
A Phase 3 trial evaluating a dual therapy of lamivudine and raltegravir in virologically suppressed HIV-1 patients has been terminated.
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: A Social Media Intervention to Improve Retention in Care for Adolescents and Young Adults With HIV in Uganda [NA]
A clinical trial in Uganda tests a social media intervention to improve retention in care among adolescents and young adults with HIV and is…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Integrated e-Health (Electronic Health) for HIV and Substance Use Disorders in Justice Involved Women [Phase 4]
A Phase 4 clinical trial conducted by Yale University evaluating integrated e-Health tools for HIV and opioid use disorder in justice-involv…
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: Adapting the Finding Respect and Ending Stigma Around HIV (FRESH) Intervention for the Dominican Republic [NA]
This entry notes the completion of the FRESH intervention trial adapted for the Dominican Republic, aiming to reduce stigma around HIV. Resu…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: Our Family Our Future: A Resilience-oriented Family Intervention to Prevent Adolescent HIV/STI Infection and Depression in South Africa [Phase 3]
Phase 3 trial in South Africa evaluating a resilience-oriented family intervention to prevent adolescent HIV/STI infection and depression ha…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Selection of Resistant Mutations to Dolutegravir in PLWH Treated in Mozambique
This Mozambican clinical trial is studying the development of resistance mutations to dolutegravir in people living with HIV on ART. It is c…
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: CASI-Plus mHealth for Ukraine's APS Program (Aim 1)
A clinical trial evaluating CASI-Plus mHealth for Ukraine's APS program has completed. The snippet lists HIV infection as the condition.
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Delivering a Multi-disease Screening Tool to Migrant Populations [NA]
This update reports the completion of a trial evaluating a multi-disease screening tool for migrant populations. The study targeted HIV, hep…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Improving HIV Adherence Care for Key Populations in India [NA]
This clinical trial update describes ongoing efforts to improve adherence to HIV treatment among key populations in India.
-
FDA approval · 2025-05-13FDA Approved: MARAVIROC — Original Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved an original ANDA for Maraviroc submitted by Zydus Pharmaceuticals USA Inc., authorizing a generic version of the HIV-1 entr…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: Fostemsavir Compassionate Use Named Patient Program for the Treatment of Human Immunodeficiency Virus 1 (HIV-1)
This clinical-trial update describes ViiV Healthcare's compassionate-use named-patient program for fostemsavir to treat HIV-1 infection.
-
FDA approval · 2025-05-12FDA Approved: EVOTAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for EVOTAZ (atazanavir and cobicistat) from E.R. Squibb & Sons, L.L.C., indicating a modification to…
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: OraQuick® HIV Self-Test Study in Canada [NA]
A Canadian clinical trial evaluating OraQuick HIV Self-Test has completed enrollment and posted results as of May 11, 2025.
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: Project MATLINK: Development and Evaluation of a Screening, Brief Intervention, & Referral to Treatment (SBIRT) Program for Opioid Dependent Prisoners and Probationers Transitioning to the Community [NA]
This completed clinical trial evaluated a Screening, Brief Intervention, and Referral to Treatment (SBIRT) program for opioid-dependent pris…
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: Implementation of STTR Strategies Among People Who Inject Drugs in Malaysia [NA]
A Yale University–sponsored clinical trial in Malaysia evaluating STTR strategies for people who inject drugs has been suspended; participan…
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: Peru Decentralized HIV Care [NA]
A Yale University–sponsored clinical trial in Peru is evaluating decentralized HIV care and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-05-11Clinical Trial Update: PRIDE III Prison Interventions and HIV Prevention Collaboration [NA]
A Yale-led clinical trial, PRIDE III Prison Interventions and HIV Prevention Collaboration, is currently recruiting participants for HIV inf…
-
CLINICAL_TRIALS research · 2025-05-09Clinical Trial Update: A Multilevel, Multiphase Optimization Strategy for PrEP (MOST:PrEP) [NA]
This ClinicalTrials.gov entry indicates that the MOST:PrEP trial, sponsored by Henry Ford Health System, is currently enrolling by invitatio…
-
CLINICAL_TRIALS research · 2025-05-09Clinical Trial Update: Optimizing PrEP Uptake and Adherence Among Male Sex Workers [NA]
A clinical trial update describing ongoing efforts to optimize uptake and adherence to pre-exposure prophylaxis (PrEP) among male sex worker…
-
FDA approval · 2025-05-08FDA Approved: LAMIVUDINE — Supplemental Application (Camber Pharmaceuticals, Inc.)
The FDA approved a supplemental application for lamivudine submitted by Camber Pharmaceuticals, expanding the approved product to lamivudine…
-
FDA approval · 2025-05-08FDA Approved: ATAZANAVIR — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for Camber Pharmaceuticals' generic atazanavir. Atazanavir is used in the treatment of HIV infection…
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: Study of Novel Antiretrovirals in Participants With HIV-1 [Phase 1]
This Phase 1 trial of novel antiretrovirals in people with HIV infection has completed and results have been posted.
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: Italian Registry of HIV-1 Infected Patients With Drug-RESistant Virus to Reverse Transcriptase Inhibitors, InteGrasE and Viral Protease.
An ongoing Italian registry trial enrolling HIV-1-infected patients with multi-drug resistance to investigate treatment strategies using int…
-
CLINICAL_TRIALS research · 2025-05-07Clinical Trial Update: Cohort Study of HIV-positive People, Treated With Long Acting Antiretroviral Therapy
This clinical trial update describes a cohort study of HIV-positive individuals treated with long-acting antiretroviral therapy. The study i…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Safety and Pharmacokinetics of the Combination Broadly Neutralizing Antibodies, 3BNC117-LS-J and 10-1074-LS-J, in Healthy American and African Adults [Phase 1, Phase 2]
Phase 1/2 trial update reporting safety and pharmacokinetics data for the combination broadly neutralizing antibodies 3BNC117-LS-J and 10-10…